Handbook

S

Sana (MVD-1)

Elite Research

SANA, also known as MVD-1, is an experimental oral drug being developed for obesity & metabolic disease. It’s a small molecule derived from salicylic acid not a peptide

It works by stimulating creatine dependent thermogenesis a process in fat cells that uses energy to produce heat, increasing calorie expenditure

Studies showed weight loss without reduced food intake, along with improvements in insulin resistance & fatty liver

Research application

Copied from the handbook as research notes. and not instructions.

In a published Phase 1 human trial, SANA/MVD-1 was taken orally at these doses:

  • 100mg every 12 hours - 15 days
  • 150mg/12hrs - 15 days
  • 200mg/12hrs - 15 days
  • Adverse side effects have been observed at 800mg and up

Unless other wise noted intermuscular (IM) peptides are commonly administered via subcutaneous (SQ) injection with 30-31 gauge syringes

From @BowTiedYukon

Read this first

The information provided is for educational and informational purposes only and is not medical advice. Always consult with your physician or a qualified healthcare provider before starting any health protocol or using any peptides

YOU assume full responsibility for YOUR actions and decisions. Do YOUR own research and make informed choices in consultation with a licensed medical professional

This guide is an independent work created by the author. It is not affiliated with, endorsed by, or associated with any company or organization

All peptides discussed are intended for research use only. They are not intended for human or animal consumption or for use in any diagnostic or therapeutic purposes

Unless other wise noted intermuscular (IM) peptides are commonly administered via subcutaneous (SQ) injection with 30-31 gauge syringes

This app is an alphabetical reader for BowTiedYukon’s free Peptide Handbook. It is not affiliated with Elite Research USA. His profile lists the code YUKON10.

@BowTiedYukon